New Times,
New Thinking.

  1. Business
  2. Economics
19 December 2012

SMF wins at Christmas cards

"Retiring Rudolph"

By Alex Hern

The winner of this year’s Christmas card competition (yes, there was a competition, didn’t you know?) is the Social Market Foundation, whose card is a perfect parody of their own reports. Click for a bigger version:

The text on the back says:

The debacle surrounding the refranchising of Santa’s West Coast Sleighline has thrown gift distribution policy into a snow flurry this Christmas.

Last month, Rudolph’s operation of the line came to an abrupt end, as purple-nosed reindeer Prancer was unexpectedly awarded the contract. But, as Rudolph languished in unseasonably bad-tempered retirement, the Partnership of Lapland Elves and Baubles (P.L.E.B.s) uncovered significant technical flaws in the bidding process, based on risky stocking capacity projections.

Select and enter your email address Your weekly guide to the best writing on ideas, politics, books and culture every Saturday. The best way to sign up for The Saturday Read is via saturdayread.substack.com The New Statesman's quick and essential guide to the news and politics of the day. The best way to sign up for Morning Call is via morningcall.substack.com
Visit our privacy Policy for more information about our services, how Progressive Media Investments may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.
THANK YOU

In this year’s Christmas commission, the SMF research fairies propose a radical overhaul of the tendering process to ensure that such problems don’t snowball in future.

“This is virgin’ on the ridiculous. Unless we sort this thing out, next year there’ll be 12 drummers drumming before we get the gifts out.”
– The Ombusnowman

Sponsor: Virgin Mary

Content from our partners
Unlocking investment in UK life sciences through manufacturing
Data defines a new era for fundraising
A prescription for success: improving the UK's access to new medicines